Average cost of drugs for extensively drug-resistant tuberculosis in Moldova
Moldova: Average cost of drugs for extensively drug-resistant tuberculosis was 1,400 constant 2022 US$ in 2024. ◆ Volatile
Average cost of drugs for extensively drug-resistant tuberculosis in Moldova, 2017–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
The most recent figure for average cost of drugs for extensively drug-resistant tuberculosis in Moldova is 1,400 constant 2022 US$, measured in 2024. That is the lowest value across all 8 years on record.
Compared with earlier readings it is down 2.4% on the previous year and down 81.1% over ten years.
Moldova ranks 36th of 56 countries on this measure, in the middle of the range.
Average cost of drugs for extensively drug-resistant tuberculosis in Moldova, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 7,427 constant 2022 US$ | — |
| 2018 | 7,427 constant 2022 US$ | +0.0% |
| 2019 | 2,911 constant 2022 US$ | -60.8% |
| 2020 | 3,145 constant 2022 US$ | +8.0% |
| 2021 | 5,199 constant 2022 US$ | +65.3% |
| 2022 | 3,671 constant 2022 US$ | -29.4% |
| 2023 | 1,435 constant 2022 US$ | -60.9% |
| 2024 | 1,400 constant 2022 US$ | -2.4% |
Moldova compared with similar countries
- Moldova's 1,400 constant 2022 US$ is below the median for upper middle income countries, which is 2,000 constant 2022 US$, 70% of the median. (23 countries reporting)
- Moldova's 1,400 constant 2022 US$ is below the median for Europe & Central Asia, which is 4,345 constant 2022 US$, 32% of the median. (8 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 5,922 constant 2022 US$ | 2,911 constant 2022 US$ | 7,427 constant 2022 US$ | 3 |
| 2020s | 2,970 constant 2022 US$ | 1,400 constant 2022 US$ | 5,199 constant 2022 US$ | 5 |
Countries ranked near Moldova
More reference data data for Moldova
- Emission Totals - Indirect emissions (N2O) - Manure applied to Soils 0.2466 (2050)
- Emission Totals - Indirect emissions (N2O) - Manure left on Pasture 0.1366 (2050)
- Emission Totals - Indirect emissions (N2O) - IPCC Agriculture 0.6117 (2050)
- Emission Totals - Indirect emissions (N2O) - Crop Residues 0.118 (2050)
- Emission Totals - Indirect emissions (N2O) - Agricultural Soils 0.6117 (2050)
- Emission Totals - Emissions (N2O) - Manure applied to Soils 0.8268 (2050)
- Emission Totals - Emissions (N2O) - Manure Management 0.4303 (2050)
- Emission Totals - Emissions (N2O) - Manure left on Pasture 0.5193 (2050)
- Emission Totals - Emissions (N2O) - IPCC Agriculture 2.92 (2050)
- Emission Totals - Emissions (N2O) - Crop Residues 0.6426 (2050)
Frequently asked questions
- What is average cost of drugs for extensively drug-resistant tuberculosis in Moldova?
- Average cost of drugs for extensively drug-resistant tuberculosis in Moldova was 1,400 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of drugs for extensively drug-resistant tuberculosis recorded in Moldova?
- The highest recorded value was 7,427 constant 2022 US$ in 2017.
- What is the lowest average cost of drugs for extensively drug-resistant tuberculosis recorded in Moldova?
- The lowest recorded value was 1,400 constant 2022 US$ in 2024.
- How does Moldova rank for average cost of drugs for extensively drug-resistant tuberculosis?
- Moldova ranks 36th out of 56 countries with data for 2024.
- Is average cost of drugs for extensively drug-resistant tuberculosis rising or falling in Moldova?
- Over the last ten years it is down 81.1%. The long-run trend across the full record is volatile.
- Where does this Moldova data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.